Inducing expression of ICOS-L by oncolytic adenovirus to enhance tumor-specific bi-specific antibody efficacy

被引：0
|
作者：
Neshat Saffarzadeh
Emelie Foord
Eoghan O’Leary
Rand Mahmoun
Thomas Birkballe Hansen
Victor Levitsky
Thomas Poiret
Michael Uhlin
机构：
[1] Karolinska Institutet,Department of Clinical Science, Intervention and Technology
[2] ANA Futura,Department of Immunology and Transfusion Medicine
[3] Circio AB,undefined
[4] Karolinska University Hospital,undefined
来源：
Journal of Translational Medicine | / 22卷
关键词：
Oncolytic virus; ICOS; Bi-specific antibody; T cell; Immunotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Inducing expression of ICOS-L by oncolytic adenovirus to enhance tumor-specific bi-specific antibody efficacy
    Saffarzadeh, Neshat
    Foord, Emelie
    O'Leary, Eoghan
    Mahmoun, Rand
    Hansen, Thomas Birkballe
    Levitsky, Victor
    Poiret, Thomas
    Uhlin, Michael
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [2] An oncolytic adenovirus redirected with a tumor-specific T cell
    Sebestyen, Zsolt
    de Vrij, Jeroen
    Magnusson, Maria
    Debets, Reno
    Willemsen, Ralph
    [J]. HUMAN GENE THERAPY, 2007, 18 (10) : 978 - 978
  • [3] An oncolytic adenovirus redirected with a tumor-specific T-Cell receptor
    Sebestyen, Zsolt
    de Vrij, Jeroen
    Magnusson, Maria
    Debets, Reno
    Willemsen, Ralph
    [J]. CANCER RESEARCH, 2007, 67 (23) : 11309 - 11316
  • [4] Tumor-specific oncolytic adenovirus expressing trastuzumab antibody for treatment of HER2-positive cancer
    Liikanen, I.
    Guse, K.
    Gutmann, T.
    Savola, P.
    Tahtinen, S.
    Pesonen, S. K.
    Oksanen, M.
    Kanerva, A.
    Hemminki, A.
    [J]. HUMAN GENE THERAPY, 2015, 26 (10) : A92 - A92
  • [5] The In Vivo Therapeutic Efficacy of the Oncolytic Adenovirus Delta24-RGD Is Mediated by Tumor-Specific Immunity
    Kleijn, Anne
    Kloezeman, Jenneke
    Treffers-Westerlaken, Elike
    Fulci, Giulia
    Leenstra, Sieger
    Dirven, Clemens
    Debets, Reno
    Lamfers, Martine
    [J]. PLOS ONE, 2014, 9 (05):
  • [6] Tumor-specific oncolytic adenovirus coding for trastuzumab results in local production of functional monoclonal antibody from tumor cells
    Liikanen, Ilkka
    Savola, Paula
    Hemminki, Akseli
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [7] Recombinant adenovirus vectors for tumor-specific gene delivery and expression
    Lieber, A
    Steinwaerder, D
    Mi, J
    Shayakhmetov, D
    [J]. CANCER GENE THERAPY, 2001, 8 (09) : 687 - 688
  • [8] Anti-tumor efficacy employing oncolytic adenovirus specific for hepatocellular carcinoma
    Li, YH
    Chen, Y
    Amin, P
    Henderson, D
    Yu, DC
    [J]. CANCER GENE THERAPY, 2001, 8 : S16 - S16
  • [9] Evasion of Antiviral Immune Response and Improvement in Tumor-Specific Localization of Oncolytic Adenovirus by Hydrogel System
    Jung, Bo-Kyeong
    Oh, Eonju
    Hong, JinWoo
    Lee, Yunki
    Park, Ki Dong
    Yun, Chae-Ok
    [J]. MOLECULAR THERAPY, 2018, 26 (05) : 332 - 332
  • [10] Bi-specific T-cell engager-armed oncolytic adenoviruses as a strategy to improve antitumor efficacy
    Alberto Fajardo, Carlos
    Moreno, Rafael
    Alfonso Rojas, Luis
    Arias, Marcel
    Alemany, Ramon
    [J]. HUMAN GENE THERAPY, 2015, 26 (09) : A13 - A14
12345